Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus brevis SBC8803 and Improved Atopic Dermatitis Symptoms

Research synthesisLow evidenceSmall effect3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies (all review articles), all reported beneficial effects on atopic dermatitis symptoms, with predominantly small effect sizes. No statistically significant findings were reported. The evidence base is small and limited to reviews without original patient data; most studies focused on children but population specifics are lacking.

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. Available evidence is overwhelmingly positive, but clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Many of the included studies did not reach statistical significance — effect may be smaller than the predominant direction suggests. Additionally, all three studies are review articles, not original clinical trials, limiting the strength of the conclusions.

Generated Jun 11, 2026
3 of 3 papers
Back to top